The profile of patients followed at the Neuroimmunology Clinic at UNIFESP: 20 years analysis
Open accessAbstract
Objective To describe the clinical activities at the Neuroimmunology Clinic of the Universidade Federal de São Paulo (UNIFESP) from 1994 to 2013. Method The final diagnosis of all patients that attended the center was reviewed and established upon specific guidelines for each disease. The number of total appointments and extra clinical activities (reports and prescriptions) were also analyzed, as are part of routine activities. Results 1,599 patients attended the Clinic from 1994 to 2013: 816 with multiple sclerosis (MS), 172 with clinical isolated syndromes, 178 with neuromyelitis optica (NMO), 216 with other demyelinating disease, 20 with metabolic disorder, 42 with a vascular disease and 155 with other or undetermined diagnosis. A mean 219 outpatient visits and 65 extra clinical activities were performed monthly. Conclusion We identified that 15% of patients seen have NMO. As patients with NMO have a more severe disease than MS, this data may be important for planning local health care policies.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A retrospective review of all patients presenting to a Brazilian demyelinating disease center from 1994 to 2013 found that 495 out of 1599 (31%) did not have MS, of whom 108 (22%) had 'other diagnosis', which included psychiatric disorders, although the proportion was not specified.
“A retrospective review of all patients presenting to a Brazilian demyelinating disease center from 1994 to 2013 found that 495 out of 1599 (31%) did not have MS, of whom 108 (22%) had “other diagnosis”, which included psychiatric disorders, although the proportion was not specified [25].”
From Functional neurological disorder and multiple sclerosis: a systematic review of misdiagnosis and clinical overlap (2022) · cites this paper as [25]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Krupp, L. B., Tardieu, M., Amato, M. P., Banwell, B., Chitnis, T., Dale, R. C., Ghezzi, A., Hintzen, R., Kornberg, A., Pohl, D., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513484547 · Cited by 1,130 · see citing works
Epidemiology and natural history of multiple sclerosis: new insights
Kantarci, O., & Wingerchuk, D. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000227033.47458.82 · Cited by 156 · see citing works
Flagged first, then by citations
Research works printed but not linked: 23
- Adelman G, Rane SG, Villa KF. The cost burden of multiple sclerosis in the United States: a systematic review of the literature. J Med Econ. 2013;16(5):639-47. http://dx.doi.org/10.3111/13696998.2013.778268 · DOI
- Jacob A, McKeon A, Nakashima I, et al. Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. J Neurol Neurosurg Psychiatry. 2013;84(8):922-30. http://dx.doi.org/10.1136/jnnp-2012-302310 · DOI
- Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology. 1996;46(4):907-11. http://dx.doi.org/10.1212/WNL.46.4.907 · DOI
- Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA, Weinshenker BG. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology. 2007;68(8):603-5. http://dx.doi.org/10.1212/01.wnl.0000254502.87233.9a · DOI
- Bichuetti DB, Oliveira EM, Souza NS, Rivero RL, Gabbai AA. Neuromyelitis optica in Brazil: a study on clinical and prognostic factors. Mult Scler. 2009;15(5):613-9. http://dx.doi.org/10.1177/1352458508101935 · DOI
- Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302. http://dx.doi.org/10.1002/ana.22366 · DOI · Paper page
- Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485-9. http://dx.doi.org/10.1212/01.wnl.0000216139.44259.74 · DOI
- Courtney AM, Treadaway K, Remington G, Frohman E. Multiple sclerosis. Med Clin North Am. 2009;93(2):451-76. http://dx.doi.org/10.1016/j.mcna.2008.09.014 · DOI
- Callegaro D, Goldbaum M, Morais L, et al. The prevalence of multiple sclerosis in the city of Sao Paulo, Brazil, 1997. Acta Neurol Scand. 2001;104(4):208-13. http://dx.doi.org/10.1034/j.1600-0404.2001.00372.x · DOI
- Lana-Peixoto MA, Frota ER, Campos GB, Monteiro LP, Brazilian Committee for Treatment and Research in Multiple Sclerosis. The prevalence of multiple sclerosis in Belo Horizonte, Brazil. Arq Neuropsiquiatr. 2012;70(2):102-107. http://dx.doi.org/10.1590/S0004-282X2012000200006 · DOI
- Bichuetti DB, Oliveira EM, Souza NA, Tintore M, Gabbai AA. Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease. Arq Neuropsiquiatr 2013;71(5):275-9. http://dx.doi.org/10.1590/0004-282X20130020 · DOI
- Brum DG, Barreira AA, Santos AC, Kaimen-Maciel DR, Mariello M, Costa RM et al. HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis. Mult Scler. 2010;16(1):21-9. http://dx.doi.org/10.1177/1352458509350741 · DOI
- Brum DG, Luizon MR, Santos AC, Lana-Peixoto MA, Rocha CF, Brito ML et al. European ancestry predominates in neuromyelitis optica and multiple sclerosis patients from Brazil. PLoS ONE. 2013;8(3):e58925.
- Matiello M, Schaefer-Klein J, Brum DG, Atkinson EJ, Kantarci OH, Weinshenker BG. HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica. Mult Scler. 2010;16(8):981-4. http://dx.doi.org/10.1177/1352458510374340 · DOI
- Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008;14(9):1157-74.
- Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53(5):1107-14. http://dx.doi.org/10.1212/WNL.53.5.1107 · DOI
- Trebst C, Jarius S, Berthele A, Paul F, Schippling S, Wildemannn B et al. Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol. 2014;261(1):1-16. http://dx.doi.org/10.1007/s00415-013-7169-7 · DOI · Paper page
- Arias M, Dapena D, Arias-Rivas S, Costa E, López A, Prieto JM et al. Late onset multiple sclerosis. Neurologia. 2011;26(5):291-6. http://dx.doi.org/10.1016/j.nrl.2010.09.008 · DOI
- Río J, Comabella M, Montalban X. Multiple sclerosis: current treatment algorithms. Curr Opin Neurol. 2011;24(3):230-7. http:// dx.doi.org/10.1097/WCO.0b013e328346bf66 · DOI
- Bichuetti DB, Oliveira EM, Boulos FC, Gabbai AA. Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients. Arch Neurol. 2012;69(7):938-9. http://dx.doi.org/10.1001/ archneurol.2012.545 · DOI
- Bichuetti DB, Boulos F, Shinosaki JS, Souza N, Oliveira E, Gabbai A. Treatment of neuromyelitis optica with intravenous immunoglobulin: report of 8 Patients. Neurology. 2012;78(Meeting Abstracts 1):PO4.141. http://dx.doi.org/10.1212/WNL.78.1_MeetingAbstracts. P04.141 · DOI
- Bichuetti DB, Oliveira EMl, Oliveira DM, Souza Na, Gabbai AA. Neuromyelitis optica treatment: analysis of 36 patients. Arch Neurol. 2010;67(9):1131-6. http://dx.doi.org/10.1001/archneurol.2010.203 · DOI
- Oliveira EML, Souza NA, Bichuetti DB, Oliveira DM, Annes M, Gabbai AA. Multiple sclerosis in Brazil: 1994-2005, a Brazilian experience. In: 22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); 2006; Madrid. Madri: SAGE; 2006.
Cited by
Sorted by citations
Walzl, D., Solomon, A. J., & Stone, J. (2022) · Journal of Neurology · doi:10.1007/s00415-021-10436-6 · Cited by 62 · see citing works
- Authors
- Bichuetti, D. B., Falcão, A. B., Boulos, F. D. C., Morais, M. M. D., Lotti, C. B. D. C., Fragomeni, M. D. O., Campos, M. F., Souza, N. A. D., & Oliveira, E. M. L.
- Affiliations
- Universidade Federal de São Paulo (BR)
- Universidade Federal de São Paulo, Brazil
- ORCID
- Venue
- Arquivos de Neuro-Psiquiatria
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2015-04
- Volume
- 73
- Issue
- 4
- Pages
- 304-308
- ISSN
- 0004-282X (ISSN-L)
- OpenAlex
- W1896667771
- Cited by
- 12
- References
- 2
- Citations by year
- 2024: 1 · 2022: 2 · 2021: 2 · 2020: 1 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 2
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Arquivos de Neuro-Psiquiatria (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Americanae (AECID Library) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Funders
- Sanofi
- Biogen
- Teva Pharmaceutical Industries
- Sanofi Genzyme
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Keywords
- multiple sclerosis, neuromyelitis optica, clinically isolated syndrome, demyelinating disease, outpatient visits, health planning, patient characteristics
- MeSH terms
- Brazil, Cross-Sectional Studies, Demyelinating Diseases, Hospitals, University, Humans, Metabolic Diseases, Multiple Sclerosis, Neuromyelitis Optica, Time Factors, Vascular Diseases, Age of Onset
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
